Cargando…
Development of a FACS-based Smac/DIABLO release assay to monitor individual drug responses and to pave the way towards patient-tailored therapies
Autores principales: | Arora, Jigyasa, Zwacka, Ralf Michael, Mohr, Andrea |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4416196/ http://dx.doi.org/10.1186/1476-9255-12-S1-P5 |
Ejemplares similares
-
Role of Smac/DIABLO in cancer progression
por: Martinez-Ruiz, Gustavo, et al.
Publicado: (2008) -
Real-time single cell analysis of Smac/DIABLO release during apoptosis
por: Rehm, Markus, et al.
Publicado: (2003) -
Novel link between E2F1 and Smac/DIABLO: proapoptotic Smac/DIABLO is transcriptionally upregulated by E2F1
por: Xie, Wei, et al.
Publicado: (2006) -
Potency and Selectivity of SMAC/DIABLO Mimetics in Solid Tumor Therapy
por: Zhao, Xiao-Yun, et al.
Publicado: (2020) -
SMAC/Diablo controls proliferation of cancer cells by regulating phosphatidylethanolamine synthesis
por: Pandey, Swaroop Kumar, et al.
Publicado: (2021)